Idra evaluates all tear fi lm layers, including lipid layer thickness and meibomian glands, to identify specifi c types of DED and provide personalized treatment recommendations relative to the patient’s needs.
BENEFITS OF USING IDRA:
$12,000.00
Each device operates on the intuitive Instrument Control Platform (ICP)—a user-friendly software designed to perform and analyze comprehensive ocular surface testing with ease. ICP enables you to save, print, and share detailed reports with patients, create customized treatment protocols, or utilize pre-set options.
With its customizable test wizard, ICP streamlines the diagnostic process by guiding you step-by-step through required exams, helping reduce analysis time and improve overall workflow efficiency.
Measure lipid layer thickness and assess abnormalities in lipid production to help identify evaporative dry eye and Meibomian Gland Dysfunction (MGD).
Evaluate tear film stability with a non-invasive break-up time measurement captured through a single, automated video acquisition.
Evaluate the structure and dropout rate of the meibomian glands in both the upper and lower eyelids to support accurate dry eye assessment.
Examine the aqueous layer of the tear film with the non-invasive Tear Meniscus test, evaluating the height, shape, and uniformity of the tear meniscus for comprehensive dry eye assessment.
Algorithm-driven treatment recommendations that can be fully customized to fit each patient’s needs.
